Patents by Inventor Ronald J. Lebel

Ronald J. Lebel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6974437
    Abstract: An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur. Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur. The accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: December 13, 2005
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Timothy J. Starkweather, Philip T. Weiss
  • Patent number: 6958705
    Abstract: An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur. Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur. The accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: October 25, 2005
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Sam W. Bowman, IV, Timothy J. Starkweather
  • Patent number: 6950708
    Abstract: An implanted medical device (e.g. infusion pump) and an external device communicate with one another via telemetry messages that are receivable only during windows or listening periods. Each listening period is open for a prescribed period of time and is spaced from successive listening periods by an interval. The prescribed period of time is typically kept small to minimize power consumption. To increase likelihood of successful communication, the window may be forced to an open state, by use of an attention signal, in anticipation of an incoming message. To further minimize power consumption, it is desirable to minimize use of extended attention signals, which is accomplished by the transmitter maintaining an estimate of listening period start times and attempting to send messages only during listening periods. In the communication device, the estimate is updated as a result of information obtained with the reception of each message from the medical device.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: September 27, 2005
    Assignee: Medtronic Minimed, Inc.
    Inventors: Sam W. Bowman IV, Ronald J. Lebel, Daniel H. Villegas, John C. Gord
  • Patent number: 6915147
    Abstract: A sensing apparatus with a connector, a sensor lead and a sensor module with a spacer placed over electrodes that have been deposited on a substrate. The spacer may have a space for receiving an enzyme. End portions of the sensor module may be encapsulated, such as with molded beads. A sensor lead may attach to the sensor module and may have an outer tubing that passes over the module and attaches to the beads at the end of the sensor module. The sensor lead may also attach to the connector such that the sensing apparatus may be electrically coupled to a pump, electronics or other devices. The sensing apparatus may be implanted into a vein or artery.
    Type: Grant
    Filed: December 28, 2001
    Date of Patent: July 5, 2005
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Rajiv Shah, Yanan Zhang, Edward Chernoff, Rudolph A. Montalvo
  • Patent number: 6873268
    Abstract: An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur. Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur. The accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: March 29, 2005
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Sam W. Bowman, IV, Timothy J. Starkweather
  • Patent number: 6827702
    Abstract: A system and process for providing safety limits on the delivery of an infusion formulation by an infusion pump system in response to a sensed biological state. The safety limits may comprise user-initiated event signals corresponding to events that may significantly affect the biological state. The safety limits may further comprise user-initiated event ranking signals for respective events which specify a degree, quantity, or measure for the respective event. The user-initiated event and event ranking signals may be communicated to a computing element associated with the infusion pump by an associated communication device having a user interface which comprises a plurality of user-selectable operators for entering information about the events and event rankings.
    Type: Grant
    Filed: December 26, 2001
    Date of Patent: December 7, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Timothy Starkweather
  • Publication number: 20040236201
    Abstract: A sensing apparatus with a connector, a sensor lead and a sensor module with a spacer placed over electrodes that have been deposited on a substrate. The spacer may have a space for receiving an enzyme. End portions of the sensor module may be encapsulated, such as with molded beads. A sensor lead may attach to the sensor module and may have an outer tubing that passes over the module and attaches to the beads at the end of the sensor module. The sensor lead may also attach to the connector such that the sensing apparatus may be electrically coupled to a pump, electronics or other devices. The sensing apparatus may be implanted into a vein or artery.
    Type: Application
    Filed: June 29, 2004
    Publication date: November 25, 2004
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Ronald J. Lebel, Rajiv Shah, Yanan Zhang, Edward Chernoff, Rudolph A. Montalvo
  • Publication number: 20040225338
    Abstract: An implanted medical device (e.g. infusion pump) and external device communicate with one another via telemetry wherein messages are transmitted under a robust communication protocol. The communication protocol gives enhanced assurance concerning the integrity of messages that impact medical operations of the implantable device. Messages are transmitted using a multipart format that includes a preamble, a frame sync, a telemetry ID, data, and a validation code. The data portion of the message includes an op-code that dictates various other elements that form part of the message. The data portion may also include additional elements such as sequence numbers, bolus numbers, and duplicate data elements. A telemetry ID for the transmitting device may be implicitly embedded in the message as part of the validation code that is sent with the message and that must be pre-known by the receiver to confirm the integrity of the received message.
    Type: Application
    Filed: June 15, 2004
    Publication date: November 11, 2004
    Applicant: Medtronic MiniMed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Sam W. Bowman, Timothy J. Starkweather, Philip T. Weiss, Robert C. Dennard, John T. Armstrong, John D. Richert
  • Publication number: 20040220517
    Abstract: A system and method for providing closed loop infusion formulation delivery which accurately calculates a delivery amount based on a sensed biological state by adjusting an algorithm's programmable control parameters. The algorithm calculates a delivery amount having proportional, derivative, and basal rate components. The control parameters may be adjusted in real time to compensate for changes in a sensed biological state that may result from daily events. Safety limits on the delivery amount may be included in the algorithm. The algorithm may be executed by a computing element within a process controller for controlling closed loop infusion formulation delivery. The biological state is sensed by a sensing device which provides a signal to the controller. The controller calculates an infusion formulation delivery amount based on the signal and sends commands to an infusion formulation delivery device which delivers an amount of infusion formulation determined by the commands.
    Type: Application
    Filed: May 20, 2004
    Publication date: November 4, 2004
    Applicant: Medtronic MiniMed, Inc.
    Inventors: Timothy J. Starkweather, Ronald J. Lebel, Rajiv Shah, Michael E. Miller
  • Patent number: 6813519
    Abstract: An implanted medical device (e.g. infusion pump) and external device communicate with one another via telemetry wherein messages are transmitted under a robust communication protocol. The communication protocol gives enhanced assurance concerning the integrity of messages that impact medical operations of the implantable device. Messages are transmitted using a multipart format that includes a preamble, a frame sync, a telemetry ID, data, and a validation code. The data portion of the message includes an op-code that dictates various other elements that form part of the message. The data portion may also include additional elements such as sequence numbers, bolus numbers, and duplicate data elements. A telemetry ID for the transmitting device may be implicitly embedded in the message as part of the validation code that is sent with the message and that must be pre-known by the receiver to confirm the integrity of the received message.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: November 2, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Sam W. Bowman, IV, Robert C. Dennard, John T. Armstrong, John D. Richert
  • Patent number: 6811534
    Abstract: An implanted medical device (e.g. infusion pump) and an external device communicate with one another via telemetry messages that are receivable only during windows or listening periods. Each listening period is open for a prescribed period of time and is spaced from successive listening periods by an interval. The prescribed period of time is typically kept small to minimize power consumption. To increase likelihood of successful communication, the window may be forced to an open state, by use of an attention signal, in anticipation of an incoming message. To further minimize power consumption, it is desirable to minimize use of extended attention signals, which is accomplished by the transmitter maintaining an estimate of listening period start times and attempting to send messages only during listening periods. In the communication device, the estimate is updated as a result of information obtained with the reception of each message from the medical device.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: November 2, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Sam W. Bowman, IV, Ronald J. Lebel, Varaz Shahmirian, Timothy J. Starkweather, Philip T. Weiss, Daniel H. Villegas, Robert C. Dennard, John T. Armstrong, John D. Richert
  • Patent number: 6811533
    Abstract: An implanted medical device (e.g. infusion pump) and external device communicate with one another via telemetry wherein messages are transmitted under a robust communication protocol. The communication protocol gives enhanced assurance concerning the integrity of messages that impact medical operations of the implantable device. Messages are transmitted using a multipart format that includes a preamble, a frame sync, a telemetry ID, data, and a validation code. The data portion of the message includes an op-code that dictates various other elements that form part of the message. The data portion may also include additional elements such as sequence numbers, bolus numbers, and duplicate data elements. A telemetry ID for the transmitting device may be implicitly embedded in the message as part of the validation code that is sent with the message and that must be pre-known by the receiver to confirm the integrity of the received message.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: November 2, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Sam W. Bowman, IV, Timothy J. Starkweather, Philip T. Weiss, Robert C. Dennard, John T. Armstrong, John D. Richert
  • Patent number: 6810290
    Abstract: A communication device (CD) exchanges messages with an implantable infusion pump via telemetry such that commands are supplied thereto and operational information is obtained therefrom. The CD is controlled, at least in part, by a processor IC according to a software program operating therein and provides feedback to a user via a visual display, an audio alarm, and a vibrational alarm, and allows input from the user via a touch sensitive keypad. Certain input functions are restricted by password. The visual display includes an icon and fixed element display region and a bitmap display region. The fixed element display region includes time and date displays, battery and drug level displays that decrement, and a moving delivery state display. Various screens allow operational or log information to be displayed and/or user entry of commands. Program features when disabled are removed from a series of screen options that can be scrolled through.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: October 26, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Daniel H. Villegas, David Y. Choy, Philip T. Weiss, Paul M. Meadows
  • Publication number: 20040210267
    Abstract: An implanted medical device (e.g. infusion pump) and external device communicate with one another via telemetry wherein messages are transmitted under a robust communication protocol. The communication protocol gives enhanced assurance concerning the integrity of messages that impact medical operations of the implantable device. Messages are transmitted using a multipart format that includes a preamble, a frame sync, a telemetry ID, data, and a validation code. The data portion of the message includes an op-code that dictates various other elements that form part of the message. The data portion may also include additional elements such as sequence numbers, bolus numbers, and duplicate data elements. A telemetry ID for the transmitting device may be implicitly embedded in the message as part of the validation code that is sent with the message and that must be pre-known by the receiver to confirm the integrity of the received message.
    Type: Application
    Filed: May 11, 2004
    Publication date: October 21, 2004
    Applicant: Medtronic MiniMed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Sam W. Bowman, Robert C. Dennard, John T. Armstrong, John D. Richert
  • Publication number: 20040193090
    Abstract: A communication device (CD) exchanges messages with an implantable infusion pump via telemetry such that commands are supplied thereto and operational information is obtained therefrom. The CD is controlled, at least in part, by a processor IC according to a software program operating therein and provides feedback to a user via a visual display, an audio alarm, and a vibrational alarm, and allows input from the user via a touch sensitive keypad. Certain input functions are restricted by password. The visual display includes an icon and fixed element display region and a bitmap display region. The fixed element display region includes time and date displays, battery and drug level displays that decrement, and a moving delivery state display. Various screens allow operational or log information to be displayed and/or user entry of commands. Program features when disabled are removed from a series of screen options that can be scrolled through.
    Type: Application
    Filed: April 14, 2004
    Publication date: September 30, 2004
    Applicants: Medtronic MiniMed, Inc., Medical Research Group, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Timothy J. Starkweather, Daniel H. Villegas, David Y. Choy, Philip T. Weiss, Colin A. Chong, Peter C. Lord, Wayne A. Morgan, Paul M. Meadows
  • Publication number: 20040133066
    Abstract: A hearing aid system including an implant (60) configured for insertion into a recess (40) formed under the skin of the retro-auricular space (50), which implant does not occlude the ear canal (30). The implant includes electronic circuitry (72), a transducer (65, e.g., speaker), antenna (64), and power source (66). The hearing aid also includes an external module (70), which module includes a microphone (163), electronics (172), antenna (164), and power source (166). A telemetry link (76) between the external module antenna and the implant antenna allows transmissions between the microphone module and the implant.
    Type: Application
    Filed: November 5, 2003
    Publication date: July 8, 2004
    Inventors: Alfred E. Mann, Albert S. Maltan, Yitzhak Zilberman, Byron L. Moran, Ronald J. Lebel
  • Patent number: 6758810
    Abstract: An implanted medical device (e.g. infusion pump) and external device communicate with one another via telemetry wherein messages are transmitted under a robust communication protocol. The communication protocol gives enhanced assurance concerning the integrity of messages that impact medical operations of the implantable device. Messages are transmitted using a multipart format that includes a preamble, a frame sync, a telemetry ID, data, and a validation code. The data portion of the message includes an op-code that dictates various other elements that form part of the message. The data portion may also include additional elements such as sequence numbers, bolus numbers, and duplicate data elements. A telemetry ID for the transmitting device may be implicitly embedded in the message as part of the validation code that is sent with the message and that must be pre-known by the receiver to confirm the integrity of the received message.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: July 6, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Timothy J. Starkweather, Philip T. Weiss, John T. Armstrong, Robert C. Dennard, John D. Richert
  • Patent number: 6740072
    Abstract: A system and method for providing closed loop infusion formulation delivery which accurately calculates a delivery amount based on a sensed biological state by adjusting an algorithm's programmable control parameters. The algorithm calculates a delivery amount having proportional, derivative, and basal rate components. The control parameters may be adjusted in real time to compensate for changes in a sensed biological state that may result from daily events. Safety limits on the delivery amount may be included in the algorithm. The algorithm may be executed by a computing element within a process controller for controlling closed loop infusion formulation delivery. The biological state is sensed by a sensing device which provides a signal to the controller. The controller calculates an infusion formulation delivery amount based on the signal and sends commands to an infusion formulation delivery device which delivers an amount of infusion formulation determined by the commands.
    Type: Grant
    Filed: December 26, 2001
    Date of Patent: May 25, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Timothy J. Starkweather, Ronald J. Lebel, Rajiv Shah, Michael E. Miller
  • Patent number: 6740075
    Abstract: A communication device (CD) exchanges messages with an implantable infusion pump via telemetry such that commands are supplied thereto and operational information is obtained therefrom. The CD is controlled, at least in part, by a processor IC according to a software program operating therein and provides feedback to a user via a visual display, an audio alarm, and a vibrational alarm, and allows input from the user via a touch sensitive keypad. Certain input functions are restricted by password. The visual display includes an icon and fixed element display region and a bitmap display region. The fixed element display region includes time and date displays, battery and drug level displays that decrement, and a moving delivery state display. Various screens allow operational or log information to be displayed and/or user entry of commands. Program features when disabled are removed from a series of screen options that can be scrolled through.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: May 25, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, Timothy J. Starkweather, Daniel H. Villegas, David Y. Choy, Philip T. Weiss, Colin A. Chong, Peter C. Lord, Wayne A. Morgan, Paul M. Meadows
  • Patent number: 6733446
    Abstract: An implanted medical device (e.g. infusion pump) and an external device communicate with one another via telemetry messages that are receivable only during windows or listening periods. Each listening period is open for a prescribed period of time and is spaced from successive listening periods by an interval. The prescribed period of time is typically kept small to minimize power consumption. To increase likelihood of successful communication, the window may be forced to an open state, by use of an attention signal, in anticipation of an incoming message. To further minimize power consumption, it is desirable to minimize use of extended attention signals, which is accomplished by the transmitter maintaining an estimate of listening period start times and attempting to send messages only during listening periods. In the communication device, the estimate is updated as a result of information obtained with the reception of each message from the medical device.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: May 11, 2004
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ronald J. Lebel, Varaz Shahmirian, John C. Gord, John T. Armstrong, John D. Richert